University Hospital Tuebingen
Clinical trials sponsored by University Hospital Tuebingen, explained in plain language.
-
New drug combo may boost stem cell transplant success in hard-to-treat blood cancers
Disease control Not yet recruitingThis study tests whether adding venetoclax to the usual pre-transplant chemotherapy (treosulfan) can safely improve survival for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). About 27 adults aged 18–75 will receive this stronger conditionin…
Phase: PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Brain and body workout at home may slow Parkinson's dementia
Disease control Not yet recruitingThis study tests a home-based program for people with Parkinson's disease who have mild memory problems and are at high risk for dementia. Participants will cycle on a stationary bike while doing brain games on a tablet, three times a week for 30 minutes. The goal is to see if th…
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New score may predict delirium after heart surgery
Knowledge-focused Not yet recruitingThis study will test a simple score to predict which patients may develop confusion (delirium) after planned heart surgery. About 100 adults will be observed before, during, and up to 10 days after surgery. The goal is to better identify high-risk patients so that prevention can …
Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:02 UTC